नेपाल सरकार - स्वास्थ्य तथा जनसंख्या मन्त्रालय
(+९७७) ०१ ४२६२५४३, ४२६२८०२, ४२६२६९६, ४२६७३७६

राष्ट्रिय क्षयराेग केन्द्र

Tuberculosis is a major public health program in Nepal with 35,000 new TB cases reported every year and increases in childhood TB and multi-drug resistant (MDR) TB with nearly 400 cases reported every year. In response to this challenge, this centre has adopted the End TB strategy with the vision to ending TB by developing targeted programmes aimed at people vulnerable to TB. Its success rests on empowering the community and greater involvement of the private sector.

Program Components and Scope of National Tuberculosis Center


Program Components

Scope, Key function


High quality DOTS and services for TB

- Expansion of Treatment Centres

- Expansion of Microscopic Centres

- Expansion of Newer diagnostic services like Genexperts and culture DST centres

- Uninterrupted, timely and adequate supply of high quality anti-TB drugs.


DR TB management

- Expansion of DR TB diagnosis and Treatment services

- Decentralised DR TB services

- Pshysosocial and rehabilitation support for DR TB patients


Private sector involvement in TB through Private-Public-Mix approach

- Identify and engage private sectors in TB diagnosis and treatment with different approaches for different type of sectors being involved which is mutually benefiting to the program and to the involved stakeholders.


Community Involvement in TB Control Program

- Identification and engagement of different community stakeholders like volunteers, FCHV and others in holding and managing TB patients through CBDOT approaches.

- Involvement of Community in supporting and rehabilitating TB patients.


Monitoring and Evaluation

- Evaluate and re-design surveillance system for TB required to timely monitor, evaluate and inform for planning to achieve the vision of elimination of TB.

- Seek to integrate with general health information system when possible.


Research and Development

- Carry out prevalence survey, TB-HIV surveillance, DRS survey and other operation research on TB.